uniQure Market Cap

uniQure has a market cap or net worth of $227.23 million as of April 23, 2024. Its market cap has decreased by -75.26% in one year.

Market Cap

227.23M

Enterprise Value

147.27M

1-Year Change

-75.26%

Ranking

#3535

Market Cap Chart

Since March 15, 2017, uniQure's market cap has increased from $161.10M to $227.23M, an increase of 41.05%. That is a compound annual growth rate of 4.96%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	230.60M	3.22%
Apr 19, 2024	223.40M	-0.84%
Apr 18, 2024	225.30M	0.85%
Apr 17, 2024	223.40M	-0.62%
Apr 16, 2024	224.80M	-0.88%
Apr 15, 2024	226.80M	-0.83%
Apr 12, 2024	228.70M	-4.95%
Apr 11, 2024	240.60M	0.21%
Apr 10, 2024	240.10M	-3.50%
Apr 9, 2024	248.80M	-
Apr 8, 2024	248.80M	0.97%
Apr 5, 2024	246.40M	-0.96%
Apr 4, 2024	248.80M	-2.24%
Apr 3, 2024	254.50M	6.84%
Apr 2, 2024	238.20M	-4.41%
Apr 1, 2024	249.20M	0.16%
Mar 28, 2024	248.80M	-3.86%
Mar 27, 2024	258.80M	1.69%
Mar 26, 2024	254.50M	-0.55%
Mar 25, 2024	255.90M	1.31%
Mar 22, 2024	252.60M	1.73%
Mar 21, 2024	248.30M	-0.76%
Mar 20, 2024	250.20M	1.96%
Mar 19, 2024	245.40M	3.20%
Mar 18, 2024	237.80M	-3.84%

View and export this data all the way back to 2017. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Adverum Biotechnologies	241.86M
Boundless Bio	238.96M
AVITA Medical	235.09M
Adaptimmune Therapeutics	235.08M
X4 Pharmaceuticals	231.77M
23andMe Holding Co.	230.25M
Conduit Pharmaceuticals	227.39M
Foghorn Therapeutics	227.22M

Market Cap Rankings